These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35883559)

  • 21. Let‑7i‑5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikrein‑related peptidase 6.
    Song J; Wang L; Ma Q; Yang Y; Yang Z; Wang B; He N
    Oncol Rep; 2018 Sep; 40(3):1459-1466. PubMed ID: 30015976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.
    Vandell AG; Larson N; Laxmikanthan G; Panos M; Blaber SI; Blaber M; Scarisbrick IA
    J Neurochem; 2008 Nov; 107(3):855-70. PubMed ID: 18778305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CEACAM5, KLK6, SLC35D3, POSTN, and MUC2 mRNA Analysis Improves Detection and Allows Characterization of Tumor Cells in Lymph Nodes of Patients Who Have Colon Cancer.
    Olsson LM; Lindmark GE; Israelsson ACE; Korkocic D; Hammarström SG; Hammarström MKC
    Dis Colon Rectum; 2021 Nov; 64(11):1354-1363. PubMed ID: 34192710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer.
    Kim JT; Song EY; Chung KS; Kang MA; Kim JW; Kim SJ; Yeom YI; Kim JH; Kim KH; Lee HG
    Cancer; 2011 Jun; 117(12):2608-19. PubMed ID: 21656738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
    Kim TW; Lee SJ; Kim JT; Kim SJ; Min JK; Bae KH; Jung H; Kim BY; Lim JS; Yang Y; Yoon DY; Choe YK; Lee HG
    Oncotarget; 2016 Dec; 7(51):85332-85348. PubMed ID: 27863404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
    Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
    Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
    Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Inoue H; Nagahara H; Murayama S; Mori M
    Clin Cancer Res; 2005 Apr; 11(8):2889-93. PubMed ID: 15837738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical pathways mediated by KLK6 protease in breast cancer.
    Pampalakis G; Zingkou E; Sidiropoulos KG; Diamandis EP; Zoumpourlis V; Yousef GM; Sotiropoulou G
    Mol Oncol; 2019 Nov; 13(11):2329-2343. PubMed ID: 30980596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
    Ehrenfeld P; Manso L; Pavicic MF; Matus CE; Borquez C; Lizama A; Sarmiento J; Poblete MT; Bhoola KD; Naran A; Figueroa CD
    Anticancer Res; 2014 Dec; 34(12):6925-38. PubMed ID: 25503118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.
    Olkhov-Mitsel E; Van der Kwast T; Kron KJ; Ozcelik H; Briollais L; Massey C; Recker F; Kwiatkowski M; Fleshner NE; Diamandis EP; Zlotta AR; Bapat B
    Epigenetics; 2012 Sep; 7(9):1037-45. PubMed ID: 22874102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.
    Walker F; Nicole P; Jallane A; Soosaipillai A; Mosbach V; Oikonomopoulou K; Diamandis EP; Magdolen V; Darmoul D
    Biol Chem; 2014 Sep; 395(9):1075-86. PubMed ID: 25153388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
    Teo CR; Casey PJ; Rasheed SA
    Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer.
    Ohlsson L; Lindmark G; Israelsson A; Palmqvist R; Öberg Å; Hammarström ML; Hammarström S
    Br J Cancer; 2012 Jun; 107(1):150-7. PubMed ID: 22699826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
    White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
    Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.
    Sidiropoulos KG; Ding Q; Pampalakis G; White NM; Boulos P; Sotiropoulou G; Yousef GM
    Mol Oncol; 2016 Aug; 10(7):993-1007. PubMed ID: 27093921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids.
    Oikonomopoulou K; Hansen KK; Baruch A; Hollenberg MD; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):747-56. PubMed ID: 18627291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors.
    Talieri M; Zoma M; Devetzi M; Scorilas A; Ardavanis A
    Tumour Biol; 2012 Oct; 33(5):1375-83. PubMed ID: 22477710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.
    Delaunay T; Deschamps L; Haddada M; Walker F; Soosaipillai A; Soualmia F; El Amri C; Diamandis EP; Brattsand M; Magdolen V; Darmoul D
    Mol Oncol; 2017 Oct; 11(10):1330-1347. PubMed ID: 28636767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck.
    Thierauf J; Veit JA; Lennerz JK; Weissinger SE; Affolter A; Döscher J; Bergmann C; Knopf A; Grünow J; Grünmüller L; Mauch C; Plinkert PK; Hoffmann TK; Hess J
    Head Neck Pathol; 2017 Sep; 11(3):314-320. PubMed ID: 27844409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.